Loeb & Loeb LLP is proud to sponsor the American Conference Institute (ACI) 12th Annual Paragraph IV Disputes Conference where partner Mark Waddell will be speaking on the panel titled "Paragraph IV Litigation Year in Review: Present Developments and Future Forecasts" taking place from April 23-25, 2018.
About the event:
Each spring, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation.
As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape, the time for this conference has never been more relevant.
For more information, including how to register, please visit the event website.
About the event:
Each spring, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation.
As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape, the time for this conference has never been more relevant.
For more information, including how to register, please visit the event website.
-
Chair, Patent Litigation & Counseling